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1. Introduction 
Haptoglobin (Hp) is an acute phase protein, primarily synthesized in the liver and secreted 
into the plasma. Hp is also produced in other tissues including lung, skin, spleen, brain, 
intestine, arterial vessels and kidney, but to a lesser extent (D'Armiento et al., 1997; Pelletier 
et al., 1998; Yang et al., 2000). The normal concentration in human plasma ranges from 0.3- 3 
mg/ml and increases several fold in the occurrence of local or systemic inflammation. 
Increased production of Hp is the result of transcriptional activation of the Hp gene 
(Baumann & Jahreis, 1983; Oliviero et al., 1987) by pro-inflammatory cytokines such as  
interleukin(IL)-1, IL-6, and Tumor Necrosis factor (TNF) (Baumann et al., 1989). The result 
of pro-inflammatory cytokine signalling is the activation of essential transcription factors 
that are needed for the expression of Hp (STAT, C/EBP, PEA3). Among vertebrate species, 
the promoter of the Hp gene is conserved and contains three key regulatory elements that 
include two C/EBP recognition sequences that flank a STAT binding site (Wang et al., 
2001). 
2. Haptoglobin structure and polymorphism 
Hp is composed of four chains: 2 -chains (~9kDa each) and 2 -chains (~33kDa each). 
Alpha and beta chains are encoded by a single gene and are synthesized as a single 
polypeptide chain that is proteolytically cleaved into a short -chain and a long -chain that 
remain connected through a disulfide bond. In addition an - unit is linked to another - 
unit also by a disulphide bond (Wejman et al., 1984).  
In humans, Hp is characterized by a genetic polymorphism which arises from differences in 
-chains while chains are identical in all Hp types. The Hp locus is located on 
chromosome 16 (16q22.1). Two common alleles exist for Hp, Hp1 and Hp2 that give rise to 
three major phenotypes. Individuals that are homozygous for allele Hp1 express the 
phenotype 1-1, those homozygous for allele Hp2, express phenotype Hp2-2, and 
heterozygous individuals express phenotype Hp1-2. The Hp1 allele is organized in 5 exons. 
The first 4 exons encode for the -subunit while exon 5 encodes for the -subunit. The Hp2 
allele consists of 7 exons, the first 6 exons encode for a larger form of subunit and exon 7 
encodes for the -subunit. The larger form of the Hp -subunit seems to originate from an 
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intragenic duplication of exons 3 and 4. As a consequence, the Hp1-1 phenotype consists of 
homodimers of two - units, but Hp1-2 and Hp2-2 consist of polymers, as the cysteine that 
forms the disulfide bond between -subunits is duplicated in Hp2. The resultant 
stoichiometry is for Hp1-1 homodimers of (1-)2; for Hp2-1 linear polymers of (1-)2 + 
(2+)n (n=0,1,2, etc); and for Hp2-2 cyclic polymers (2+)n (n=3,4 etc) (Van et al., 2004). 
The distribution of Hp1 and Hp2 alleles in the world population differs according to the 
racial origin. Native populations in South America have the highest frequency of the Hp1 
allele (0.7), while Asian populations have the lowest frequency of the Hp1 allele (0.2). The 
European population has a Hp1 allele frequency of 0.4 with a phenotypic distribution of 
approximately 15% Hp1-1, 50% Hp 1-2, and 35% Hp2-2  (Carter & Worwood, 2007). 
Importantly, the three different Hp phenotypes exhibit functional differences that can have 
clinical and biological consequences. 
 
 
Fig. 1. Schematic representation of the structure of the different haptoglobin polymers 
determined by phenotype. 
3. Haptoglobin: Biological functions 
3.1 Haptoglobin prevents oxidative stress 
Hp scavenges free hemoglobin (Hb) in the event of intravascular and/or extravascular 
hemolysis or during normal red blood cell turnover. In plasma, free Hb instantly binds Hp 
with extremely high affinity (KD ~10-15 M) but low dissociation speed, in a ratio of 1Hp:1Hb, 
to form the Hp-Hb complexes. These complexes are rapidly cleared and degraded by 
macrophages via the CD163 cell-surface receptor. CD163 receptor is expressed in monocytes 
and mature tissue macrophages. Hb-Hp complexes once internalized by tissue macrophages 
are degraded in lysosomes. The heme fraction is converted by heme oxygenase into 
bilirubin, carbon monoxide, and iron (Buehler et al., 2009). By doing so, Hp prevents the 
oxidative damage caused by free Hb. Free Hb is highly toxic due to its content of iron-heme 
that in the presence of H2O2 can generate reactive hydroxyl radicals (Fenton reaction) that in 
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turn cause damage to lipids, proteins and DNA (Lim et al., 2001). Additionally, free Hb acts 
as a potent scavenger of nitric oxide (NO), an endogenous antioxidant and a regulator of 
vascular homeostasis, via deoxygenation. NO depletion by Hb has severe consequences 
such as blood vessel constriction and pulmonary and systemic hypertension, thrombosis, 
platelet activation, and smooth muscle responses (Alayash, 2011). NO is also important as a 
toxic defence molecule against infectious organisms and regulates the functional activity, 
growth and death of many immune and inflammatory cell types that results in an anti-
inflammatory effect. The consumption of nitric oxide by Hb reduces the anti-inflammatory 
properties of NO (Tripathi, 2007).  
Independently of its binding capacity to Hb, Hp is an effective antioxidant molecule of Cu2+ 
and AAPH-induced LDL oxidation. Hp also plays a role in cellular resistance to oxidative 
stress since its expression renders cells more resistant to damage by oxidative stress induced 
by hydrogen peroxide (Tseng et al., 2004).  
Its capacity of Hp to prevent oxidative stress is directly related to its phenotype. Hp1-1 has 
been demonstrated to provide superior protection against Hb-iron driven peroxidation than 
Hp2-2. The superior antioxidant capacity of Hp1-1 seems not to be related with a dissimilar 
affinity with Hb but the functional differences may be explained by the restricted 
distribution of Hp2-2 in extravascular fluids as a consequence of its high molecular mass 
(Melamed-Frank et al., 2001).  
The lessened antioxidant function of Hp2-2 is translated into clinical consequences. For 
instance, low levels of Hp (hypo-haptoglobinemia) and the Hp2-2 phenotype are associated 
with idiopathic familial and posttraumatic epilepsy. The mechanism behind this association 
can be the defective inhibition of Hb-driven brain-lipid peroxidation after micro-
haemorrhage events within the central nervous system (CNS) caused by the null or low 
concentration of Hp in this tissue as a result of the low diffusion of Hp2-2 high molecular 
mass-polymers into the interstitial compartment of the CNS (Panter et al., 1985; Sadrzadeh 
et al., 2004). In subarachnoid haemorrhage (SAH) and intracerebral haemorrhage (ICH), Hp 
is important for protecting brain from damage caused by free Hb. In experimental SAH 
Hp1-1 showed higher protection of the brain tissue from vasospasm, inflammation and 
improved survival compared to Hp2-2 (Levy et al., 2007). In the ICH model, lack of Hp 
promoted axonal and oligodendroglia damage (Zhao et al., 2009).  
3.2 Haptoglobin beyond its antioxidative role 
Besides its anti-oxidative capacity, Hp has been demonstrated to exert direct angiogenic 
properties and to be involved in arterial restructuring. Hp has been shown to stimulate 
angiogenesis in both in vitro and in vivo models. Hp is implicated in arterial restructuring 
through the formation of a temporary gelatin-based matrix that enhances cell migration (De 
Kleijn et al., 2002). Additionally, Hp has been reported to function as an extracellular 
chaperone as it inhibits the heat and stress-induced precipitation of a wide variety of 
purified proteins by forming soluble high molecular weight complexes with missfolded 
proteins. All three phenotypes of Hp have efficient chaperone function, however Hp1-1 has 
the highest efficacy (Yerbury et al., 2005). Moreover, Hp can inhibit formation of amyloid 
fibrils from diverse proteins by interacting with prefibrillar species to maintain the solubility 
of amylodogenic proteins, avoiding the incorrect accumulation of proteins in  extracellular 
spaces (Yerbury et al., 2009).  
Haptoglobin forms part of the innate unspecific defence against pathogenic bacteria. Hp has 
a bacteriostatic role by binding Hb and preventing the utilization of iron by pathogenic 
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bacteria that require iron for their growth (Eaton et al., 1982). Hp2-2 can bind the T4 antigen 
on the surface of streptoccocus bacterium and agglutinates this pathogen, thus inhibiting its 
growth (Delanghe, J. et al., 1998). However, Hp can also have a detrimental function in 
parasite infection. Hp-Hb complexes bind a receptor expressed on Trypanosoma brucei 
surface. Parasites seem to acquire heme from Hp-Hb complexes in order to increase their 
growth rate and resistance to the oxidative response of the host to eliminate parasites. On 
the other hand, a highly similar protein to Hp called “haptoglobin related protein” (Hpr) 
binds Hb and also associates with trypanosome lytic factor (TLF). TLF is a deadly toxic 
molecule for parasites. The penetration of TLF into the parasite is mediated by Hpr-Hb 
complexes. Hpr-Hb complexes are recognized by the same trypanosomal receptor that binds 
Hp-Hb complexes (Pays & Vanhollebeke, 2009). 
The secretion of Hp is enhanced in inflammatory states, and at the same time, Hp has 
important anti-inflammatory properties. As a consequence of macrophage activation, a variety 
of inflammatory mediators are released, including prostaglandins, leukotrienes, and platelet-
activating factor, which are products of the metabolism of  the membrane polyunsaturated 
fatty acid arachidonic acid (AA) by 5-lipoxygenase (5-LO), cyclooxygenase (COX) or 
cytochrome P450 epoxygenase activity. Leukotrienes have chemotactic, chemokinetic, 
vasoactive and immunomodulatory properties. Hp possesses significant inhibitory activity on 
the biosynthesis of prostaglandins via COX and on 12-hydroxyeicosatetrenoate (12-HETE) via 
lipoxygenase (Saeed et al., 2007). Consequently, during the initial events of inflammation, Hp 
participates actively in reducing tissue damage.  
During the inflammatory process and tissue injury, proteases such as cathepsin B are 
released. Cathepsin B is an abundantly expressed cysteine peptidase involved in many 
physiological processes, such as remodelling of the extracellular matrix (wound healing), 
apoptosis, and activation of thyroxin and rennin. Cathepsin B importantly participates in 
many pathological processes, such as inflammation, parasite infection and cancer, where it 
is highly up-regulated. Hp specifically inhibits cathepsin B activity (Kalsheker et al., 1981; 
Pagano et al., 1980; Snellman & Sylven, 1967). Therefore, Hp might have a regulatory role in 
tissue proteolysis associated with the inflammatory reaction. 
Neutrophils are recruited at sites of inflammation within minutes after injury or infection. In 
this context Hp suppresses neutrophil function. Hp is synthesized in 
myelocytes/metamyelocytes during granulocyte differentiation, stored in specific granules 
of fully differentiated neutrophils and exocytosed immediately in response to activation. Hp 
binding to activated neutrophils inhibits not only the activity of both 5-LO and COX but also 
calcium influx and subsequent generation of reactive oxygen species. Hp inhibits 
respiratory burst activity in neutrophils stimulated with fMLP, arachidonic acid, and 
opsonized zymosan (Oh et al., 1990). Hp also inhibits the chemotactic response of human 
granulocytes and differentiated HL-60 cells to fMLP, but does not affect chemotaxis by IL-8. 
Hp inhibits phagocytosis and reduces intracellular bactericidal activities of granulocytes 
(Rossbacher et al., 1999; Theilgaard-Monch et al., 2006). Thus, Hp secreted at sites of injury 
or inflammation mitigates potential tissue damage locally.  
4. Haptoglobin expression, polymorphism and disease 
Expression of Hp has been associated with diverse inflammatory autoimmune diseases and 
as a marker of disease activity. Also, genetic polymorphism of Hp has been shown to 
influence the course of several inflammatory pathologies.  
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Infection 
Patients infected with HIV-1 and with Hp2-2 phenotype have a worse prognosis, related to 
a more rapid rate of viral replication, than HIV-1 infected patients with the Hp1-1 
phenotype. Hp2-2 patients also show higher iron levels and oxidize more vitamin C. It is 
possible that the less efficient protection against heme-driven oxidative stress by Hp2-2 may 
stimulate the viral replication (Delanghe, J. R. et al., 1998).  
Cancer 
High amounts of Hp in plasma and locally in tumoral tissue have been observed in diverse 
types of malignancies including, lung, bladder, breast cancer, leukemia, glioblastoma, 
malignant lymphoma, and ovarian cancer (Abdullah et al., 2009; Carter & Worwood, 2007; 
Kumar et al., 2010; Smeets et al., 2003). The suggested functions of Hp in cancer are as a 
biomarker of malignancy, as a regulator of the immune response against tumor cells, and as 
a facilitator of metastasis, since Hp seems to participate in cell migration and angiogenesis 
(Cid et al., 1993; De Kleijn et al., 2002). 
Atherosclerosis 
In cross sectional studies, the Hp2-2 phenotype is also associated with an increased risk of 
atherosclerotic vascular disease and acute myocardial infarction. The lower antioxidant 
capacity of Hp2-2 together with a lower capacity of Hp2-2 in stimulating macrophages to 
secrete anti-inflammatory cytokines after binding CD163, might be the reason why individuals 
with Hp2-2 phenotype are more susceptible for cardiovascular diseases  (Levy et al., 2007). 
Myasthenia gravis 
High serum levels of Hp have been found in patients with myasthenia gravis. Hp serum 
level is directly correlated with the severity of the disease. This correlation could be 
explained by the presence of high levels of pro-inflammatory cytokines during active 
disease. To determine the Hp serum levels in patients with myasthenia can be useful to 
monitor the severity of the disease (Oliveira et al., 2008).  
Arthritis 
In patients with active rheumatoid arthritis, high serum levels of Hp have been found. 
Levels of Hp correlate with clinical disease activity (Cylwik et al., 2010). In juvenile 
idiopathic arthritis (JIA), a heterogeneous group of inflammatory diseases, Hp was found in 
inflamed joints. Hp was locally produced in synovial fluid of patients with JIA. Moreover, 
Hp was expressed differentially between JIA subtypes. Hp expression was increased in 
systemic JIA. The presence of Hp in the inflamed tissue suggests that Hp plays a role in the 
progression and pathology of the disease and can also be used as a biomarker of disease 
activity (Rosenkranz et al., 2010). 
Psoriasis 
In psoriasis, a structure modification of Hp was described that might impair the Hb binding 
function and also the activity of the lecithin-cholesterol acyltransferase (LCTA) enzyme 
(Cigliano et al., 2008). The structural modification of Hp in psoriasis patients is an 
abundance or structure change of specific glycans that differ or do not exist in Hp from 
healthy donors. These changes are associated with altered function of that might have an 
impact on the disease activity (Maresca et al., 2010). Interestingly, it was found that there is 
no higher prevalence of any of the three phenotypes of Hp in psoriasis.  
www.intechopen.com
 
Acute Phase Proteins – Regulation and Functions of Acute Phase Proteins 234 
Lupus 
It has been shown that in systemic lupus erythematosus (SLE) patients, Hp plasma levels 
correlate with severity of the disease and that the Hp2-2 phenotype is over-represented in SLE 
patients (Pavon et al., 2006; Rantapaa et al., 1988). The association of the Hp2-2 phenotype with 
SLE can have several implications. SLE is an autoimmune disease mediated by B cells that 
secrete self-reactive pathogenic antibodies. Individuals with the Hp2-2 phenotype seem to 
have a higher number of CD22 binding sites compared to other Hp phenotypes. Additionally, 
it is known that cardiovascular disease is a common complication of SLE. The finding that 
Hp2-2 has lower anti-oxidant capacity (Van et al., 2004) might be an explication for this. 
Celiac disease 
The frequency of the Hp1-2 phenotype in celiac disease patients has been reported to be 
higher than in the general population. However, Hp2-2 phenotype was associated with a 
more severe clinical course of the disease (Papp et al., 2008). The structural differences and 
the functional differences between Hp phenotypes may account for phenotype association 
of Hp to the more severe form of celiac disease. Hp2-2-Hb complexes upon binding CD163 
induce lower expression of IL-10 compared to Hp1-1-Hb complexes. Hp2-2 is as well 
associated to a stronger immune response (Guetta et al., 2007). 
Diabetes type I 
In patients with a long duration of type I diabetes, an increased risk of cardiovascular 
disease was observed in patients with the Hp2-2 phenotype. Again, as Hp2-2 has low anti-
oxidant capacity and a low efficiency in preventing heme release, this can contribute to the 
higher cardiovascular risk in type I diabetes (Costacou et al., 2008). Also, it was shown that 
the Hp phenotype may be an independent determinant of early renal function decline and 
progression to end-stage renal disease (Costacou et al., 2009). 
Inflammatory bowel diseases (IBD) 
Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal inflammatory condition 
that is classified into two major forms, Crohn’s disease (CD) and ulcerative colitis (UC). The 
etiology is unknown, but the pathogenesis is likely dependent on the interaction between local 
immune reaction and environmental factors in susceptible individuals. To explore a possible 
role of Hp in IBD patients we recently studied polymorphisms in the Hp locus in a cohort of 
CD and UC patients. It was found that the Hp2 locus was overrepresented in CD and UC 
patients compared to healthy individuals (Marquez, et al. in press). These results indicate that 
Hp phenotype can be a risk factor for IBD. Since Hp phenotypes differ in their function, 
further research is necessary to understand how Hp genotype modulates IBD pathogenesis.  
5. Haptoglobin and the immune response  
Disease associations mentioned above are strongly suggestive for a modulatory effect of Hp 
on immune responses. Several experimental data support this concept. 
5.1 Receptors for Hp on immune cells 
The Hb-Hp complex is removed from the circulation by binding to CD163 expressed on the 
monocyte-macrophage system. CD163 is a member of the SRCR family class B and is 
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expressed on most subpopulations of mature tissue macrophages. Triggering CD163 by 
ligand binding (Hb-Hp) results in a protein tyrosine kinase-dependent signal and secretion 
of IL-6 and IL-10. Moreover, IL-6 and IL-10 are known to up-regulate CD163 and this might 
function as a positive feedback mechanism for CD163 induction. In fact, CD163 has an 
important immunomodulatory function. The Hp genotype modulates the balance of Th1 
and Th2 cytokines produced by macrophages exposed to free Hb via a CD163 dependent 
mechanism. The Hp1-1–Hb complex stimulated the secretion of significantly more IL-6 and 
IL-10 than the Hp2-2–Hb complex (Guetta et al., 2007). Moreover, CD163 also exerts an 
immunomodulatory role by degradation of heme which results in the production of 
metabolites with suggested anti-inflammatory effects (Moestrup & Moller, 2004; Nielsen et 
al., 2007).  
Hp also binds to the integrin adhesion receptor, Mac-1 (Macrophage-1 antigen, integrin 
alphaMbeta2, CD11b/CD18) (El Ghmati et al., 1996) which is expressed on dendritic cells, 
neutrophils, monocytes, macrophages, NK cells, and a small subset of T cells. Mac-1 is 
involved in maturation, phagocytosis and adhesion of monocytes and is required for 
adhesion and transmigration of monocytes into tissues. Engagement of Mac-1 by its ligands 
initiates an intracellular signalling cascade that results in activation and cytokine secretion 
(Shi et al., 2004; Shi & Simon, 2006). 
Hp is a ligand of CD22 on B cells and CD22 is implicated in B cell activation and survival 
(Langlois et al., 1997). By binding CD22, Hp can inhibit the interaction with other CD22 
ligands and as a consequence may negatively modulate the B cell function (Hanasaki et al., 
1995). 
Hp has also been demonstrated to bind a not-yet-identified receptor on mast cells 
interfering with their spontaneous proliferation (El-Ghmati et al., 2002), and perhaps with 
other functions that have not been explored. 
5.2 Immunomodulatory effects of Hp 
Hp participates actively in several processes of the immune response, from activation of the 
innate and adaptive immune response to tissue repair and regeneration. Hp released locally 
and systemically modulates numerous cellular activities, including prostaglandin synthesis, 
leukocyte activation, recruitment and migration, modulation of cytokine patterns, and tissue 
repair (Wang et al., 2001). Hp rises during inflammatory process, including those caused by 
autoimmunity, and the general picture is that Hp has an anti-inflammatory effect 
(Arredouani et al., 2005; Quaye, 2008; Wang et al., 2001).  
An anti-proliferative capacity of Hp on lymphocytes has been demonstrated in a variety of 
conditions. Purified Hp or Hp present in sera and ascites fluid of cancer patients has been 
shown to inhibit the polyclonal proliferation of mitogen-stimulated T cells (Arredouani et 
al., 2003; Oh, S. K. et al., 1987b). Hp modifies the T helper Th1/Th2 balance (Arredouani et 
al., 2003; Oh, S. K. et al., 1987a; Oh, S. K. et al., 1987b). Furthermore, Hp inhibits or enhances 
proliferation of B-cells in response to bacterial endotoxins, depending on its concentration 
(Quaye, 2008; Wang et al., 2001).  
Dendritic cells (DC) are central regulators of immune responses and the bridge between 
innate and adaptive immune response. It has been demonstrated that Hp prevents 
epidermal Langerhans cells (LC) from spontaneous functional maturation in the skin. Hp is 
stored in the epidermal LC cytoplasm, but LC do not produce Hp. Though, Hp is produced 
in keratinocytes (KC). KC play an important role in regulating the function of LC and T cells 
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in the skin by producing cytokines and possibly by expressing Hp (Li et al., 2005; Wang et 
al., 2005; Xie et al., 2000). 
5.3 Haptoglobin has a negative regulatory role in a CNS-autoimmune response 
Experimental autoimmune encephalomyelitis (EAE) is a model for organ specific 
autoimmunity. The immunopathological events of EAE encompass the initial T-cell priming 
in the secondary lymphoid organs, followed by the recruitment of primed T-cells in the CNS 
and the subsequent effector phase. Systemic immunisation with myelin antigens in CFA is 
sufficient to prime myelin-reactive T cells. Neuroantigen-reactive T cells recognize their 
cognate antigen presented by professional antigen-presenting cells (APCs) within secondary 
lymphoid organs where those cells are activated and expanded (Becher et al., 2006). Once 
myelin-reactive T cells are activated in the periphery, they migrate to the CNS traversing the 
blood brain barrier (BBB). Activated T cells in the CNS recruit other lymphocytes, 
monocytes, and granulocytes by secreting inflammatory mediators. All inflammatory 
immune cells orchestrate damage to myelin that covers axons, a process called 
demyelination. In turn, demyelination leads to a variety of neurological symptoms 
including paralysis as a final result. 
Until recently there were no studies yet that specifically analyzed the effect of Hp on 
development and course of CNS autoimmune inflammatory disease. We aimed to 
characterize the role of Hp in EAE induced by immunisation with MOG35-55 peptide in 
C57BL/6 mice. We immunised wild-type (WT) and Hp-/- C57BL/6 mice with MOG35-55 in 
complete Freunds adjuvans (CFA) and showed that Hp influences the severity of EAE, as 
the lack of Hp results in clinically and in pathologically exacerbated EAE  (Galicia et al., 
2009). Our further results indicated that Hp has an important modulatory effect on the 
infiltration of mononuclear cells into the CNS and on the production of Th1 cytokines and 
IL-17A by auto-reactive T cells. Exacerbated disease in Hp-/- mice was related to an 
increased expression of IFNIL-6 and IL-17A in the CNS of these animals. Furthermore, 
the number of IL-17+ cells in the CNS was increased (Galicia et al., 2009). Neutralization of 
IL-17A with anti-IL-17A monoclonal antibodies (mAbs) in Hp-/- mice significantly reduced 
the severity of the disease but did not completely block it as it did in WT animals (Fig2) 
(unpublished data). 
These results strongly suggest that Hp has a protective role in reducing the severity of an 
autoimmune inflammatory process, and this protection is related with the suppression of 
auto-aggressive cells that produce inflammatory cytokines.  
5.4 Haptoglobin has a regulatory role in experimental colitis  
Several animal models of inflammatory bowel disease have been developed, in which colitis 
can be induced using chemical compounds such as dextran sulphate sodium (DSS) or 
oxazolone in susceptible strains of mice. The resulting inflammation is mediated by 
polymorphonuclear cells, macrophages, and lymphocytes. Interestingly, Hp is expressed by 
intestinal epithelial cells (Pelletier et al., 1998). 
To study whether Hp has an effect on the course of inflammatory colitis, we induced colitis 
with DSS and oxazolone in wild-type and in Hp deficient mice. We found that in both forms 
of colitis, the severity of the disease was exacerbated in Hp-/- mice compared to WT. The 
more severe inflammation in Hp-/- mice was related to high mRNA expression of IL-17, 
IFN-γ, TNF and IL-6 in colonic tissue in Hp-/- DSS colitis mice, while there was a slight 
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increase in IL-13 mRNA in Hp-/- mice with oxazolone-induced colitis. In order to determine 
the immunological mechanisms for the protective role of Hp in these models, draining 
lymph nodes from DSS or oxazolone colitis mice were cultured in the presence of IL-23, a 
cytokine that contributes to the survival and effector functions of IL-17-producing cells 
(Th17). Cells obtained from DSS and oxazolone colitis Hp-/- mice produced high amounts 
of IL-17 compared with WT mice, suggesting the presence of increased numbers of Th17 
cells in Hp-/- mice. However, we found that in vitro Hp does not interfere with Th17 
differentiation but that it rather suppresses IL-17 production (Marquez, et al. in press). Thus 




Fig. 2. Blockade of IL-17A reduces the severity of EAE in WT and Hp-/- mice. Clinical scores 
of WT and Hp-/- mice immunised with MOG35-55/CFA untreated or treated with murine 
anti-mouse IL-17A mAbs. Anti-IL-17A mAb was administered intra peritoneally two times 
per week (0.2 mg/mouse) from day 7 until day 21 after immunisation. Data shown are from 
two different experiments (n=10). *p≤ 0.05. (Galicia, et al. unpublished data) 
5.5 Hp is required to induce mucosal tolerance 
The immune response serves primarily to protect the organism from foreign invading 
pathogens and tumor cells. Reduced or absent responsiveness of the immune system against 
self-antigens is necessary to allow the immune system to mount an effective response to 
eliminate infectious invaders while leaving host tissues intact. This condition is known as 
immune tolerance. Self-tolerance is maintained by central (thymus-dependent) and by 
peripheral mechanisms. The mechanism of central tolerance is the deletion of self-reactive T 
cells in the thymus during T cell maturation. During ontogeny auto-reactive cells encounter 
self-antigens in the medullary-cortical junction in the thymus, and those cells that react with 
high affinity to the antigen are eliminated in a process called negative selection (Kyewski & 
Klein, 2006). Nevertheless, some self-reactive T cells can escape from deletion in the thymus. 
These auto-reactive cells must be kept in a state of reduced or absent responsiveness to 
avoid pathogenic immune reactivity. Peripheral tolerance provides a second line of 
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protection against autoimmune responses by regulating potentially pathogenic autoreactive 
lymphocytes, a process in which  regulatory T cells have a major role  (Li & Boussiotis, 
2006). When self-tolerance is broken, the immune reaction against self-antigens can lead to 
autoimmune disease.  
Mucosal tolerance induction is a naturally occurring immunological phenomenon that 
originates from mucosal contact with inhaled or ingested proteins. The largest areas of the 
body exposed to the external environment are the mucosal surfaces. Regular contact of 
antigens with mucosal surfaces prevents harmful inflammatory responses to non-dangerous 
proteins, such as food components, harmless environmental inhaled antigens and symbiotic 
microorganisms. The lymphoid tissue associated to the mucosa of the gastrointestinal tract 
and to the airway system mucosa therefore plays an important role in tolerance 
maintenance (Dubois et al., 2005). Administration of antigens by either oral or nasal route, in 
the absence of costimulatory signals, leads to specific suppression of systemic immune 
responses against these antigens in mice. The induction of oral or nasal tolerance to antigens 
is an active process that results in anergy, generation of antigen-specific suppressive T 
lymphocytes, production of anti-inflammatory cytokines such as IL-4, IL-10 and TGF-and 
deletion of antigen reactive T cells (Dubois et al., 2005; Faria & Weiner, 2006). On the 
contrary, mucosal tolerance induction is abrogated by applying the antigen in the presence 
of an adjuvant, such as LPS or cholera toxin (Kraal et al., 2006). 
Oral and nasal tolerance has been used successfully to prevent a number of experimental 
autoimmune diseases including, arthritis, diabetes, uveitis, and EAE (Faria & Weiner, 2006). 
Particularly, administration of MOG35-55 peptide by the nasal route is highly efficient in 
suppressing EAE (Shi et al., 1998; Xu et al., 2000).  Shortly after intranasal antigen instillation 
of a soluble, harmless antigen, it can be detected in the nose-draining lymph nodes. The 
majority of inhaled antigen detected in lymph nodes is associated with a variety of dendritic 
cells (DC), such as CD8low CD205+, plasmacytoid DCs and CD8high DC (Wikstrom & 
Stumbles, 2007). These DC play a pivotal role in induction of tolerance through the 
differential expression of surface molecules and cytokines that make them able of inducing 
T-regulatory cells (Coombes et al., 2007). After antigen presentation under non-
inflammatory conditions to antigen-specific naïve CD4+ T cells, those T cells proliferate 
transiently and become tolerant. The CD4+ T cell population that arises after harmless 
antigen administration in the nose is able to transfer tolerance and to suppress specific 
immune responses in naïve animals (Unger et al., 2003).  The draining lymph nodes of the 
nose which are the internal jugular (IJLN) and superficial cervical lymph (CLN) nodes are 
essential for tolerance induction towards inhaled antigens. Removing these lymph nodes 
abrogates the capacity of nasal tolerance induction and their function cannot be restored by 
peripheral lymph nodes when transplanted to this site (Kraal et al., 2006; Wolvers et al., 
1999). Importantly, Hp expression is increased in cervical lymph nodes shortly after nasal 
protein antigen instillation without adjuvant (Boots et al., 2004). Thus, Hp might have an 
important function in nasal tolerance induction. 
Several murine models of autoimmune diseases can be prevented by nasally administering 
the self-antigens prior to disease induction with the same antigen, including EAE (Li et al., 
1998; Shi et al., 1998). To study the participation of Hp in nasal tolerance induction, we 
administrated 100µg of MOG35-55 to Hp-/- and WT sex-age matched mice by nasal 
instillation at day 7, 5, and 3 before EAE induction by immuniszation with MOG in CFA.  
The control group was given PBS as vehicle control. We found that Hp-/- mice were partly 
resistant to the development of nasal tolerance induction, as Hp-/- mice that received 
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nasally MOG peptide in the nose still developed severe EAE, while the WT mice were 
protected. These data suggest that Hp is a critical modulator of mucosal tolerance induction 
(Fig3)  (Galicia, et al. unpublished data). Lack of immune tolerance in Hp-/- mice was 




Fig. 3. Lack of Hp hampers induction of nasal tolerance. Mice received 100µg MOG35-55 or 
PBS by nasal instillation, on day 7, 5 and 3 before MOG-immunisation. EAE was induced by 
injection of MOG35-55 in CFA in the footpads. Clinical score was assessed daily. A 
representative experiment out of three independent experiments with similar results is 
shown. Each experimental group consisted of 5 mice. WT+PBS vs WT+MOG: p=0.0066; 
WT+PBS vs Hp-/- +PBS: p=0.048. Hp-/-+PBS vs Hp-/-+MOG: p=0.06. 
6. Conclusion 
Apart from the Hb scavenger function of Hp, several recent studies have revealed new 
functions of Hp on immune responses and in autoimmunity. Furthermore, Hp 
polymorphism seems to be related with the outcome of various autoimmune diseases. The 
differential capacity to prevent oxidative stress, modulation of immune responses,  and 
control of inflammation by the three major Hp phenotypes (Van et al., 2004) can account for 
differences in susceptibility to, or severity of the autoimmune inflammation. Previously, our 
laboratory demonstrated that Hp was able to modulate not only the function of T cells, by 
regulating in vivo and in vitro the Th1/Th2 response, but also macrophage cytokine 
secretion. Whereas in some cells the Hp binding receptor is known (Mac-1 on macrophages, 
dendritic cells; CD22 on B cells), additional receptors might exist. However, the evidence 
that Hp acts directly on immune cells points out that Hp plays an important negative 
regulatory role in immune response and likely in autoimmunity. To explore this hypothesis 
we used models of organ-specific autoimmunity mediated by T cells. We showed in two 
different models of autoimmune inflammation that Hp has a crucial role in controlling 
inflammation mediated by Th1 and Th17 cells. Though the mechanism behind exacerbated 
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Th1/Th17 responses is still not clear, we propose that Hp may regulate differentiation 
and/or activity of T cells indirectly through the negative regulation of dendritic cell and 
macrophage functions.  
Dendritic cells are the most efficient cells in driving the activation and differentiation of 
naïve T cells (Ueno et al., 2007). Hp has been described as an alternative low affinity ligand 
for the CD11b/CD18 (Mac-1) integrin (El Ghmati et al., 1996). Moreover, Mac-1 has been 
demonstrated to play an important role in the function of Mac-1 expressing cells and in 
migration and phagocytosis. Thus, it is likely that Hp, by binding Mac-1, may negatively 
regulate the function of dendritic cells, macrophages, and any cell that express Mac-1. 
Consequently, we propose that the lack of Hp allows for a stronger activation of DC, and 
therefore more potent activation and differentiation of auto-aggressive T cells with a pro-
inflammatory cytokine profile (Fig4).  
 
 
Fig. 4. Diagrammatic scheme of the potential mechanism of Hp regulation of immune cell 
functions. Hp is proposed to act through binding Mac-1 on dendritic cells and macrophages, 
thus reducing their activity and IL-6 secretion. Dotted arrows indicate an indirect effect of 
Hp on T cells through function modulation of macrophages and dendritic cells, resulting in 
decreased Th1 and Th17 activity.   
Our results imply that Hp can be considered as a highly relevant player in controlling 
immunity and inflammation. Additionally, we showed that Hp polymorphism is associated 
with inflammatory bowel disease. Finally, we also demonstrated that Hp is an essential 
component for the mucosal tolerance induction. Further studies are needed to obtain more 
insight into the mechanism through which Hp restrain the Th1/Th17 response and how Hp 
is relevant in creating a proper environment in the lymph nodes to induce tolerance. 
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